Abbonarsi

Mortality and rehospitalization after mitral valve surgery as a function of age and key comorbidities - 14/03/23

Doi : 10.1016/j.ahj.2023.01.006 
Eva Havers-Borgersen, MD a, , Jawad H. Butt, MD a, Jarl Strange, MD a, Christian L. Carranza, MD, PhD b, Lars Køber, MD, DMSc a, Emil L. Fosbøl, MD, PhD a
a Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark 
b Department of Cardiothoracic Surgery, Rigshopitalet, Copenhagen University Hospital, Copenhagen, Denmark 

Reprint requests: Eva Havers-Borgersen, MD, Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, 2100 København Ø, Denmark.Department of CardiologyRigshospitaletCopenhagen University HospitalBlegdamsvej 9København Ø2100Denmark

Riassunto

Background

Mitral valve surgery is associated with substantial perioperative risk and long-term complications. Data on long-term outcomes following surgery remain scarce and are hypothetically modified by age and comorbidities.

Methods

This Danish nationwide study included patients ≥60 years of age undergoing mitral valve surgery from 2000-2018. Patients were observed from day of surgery until outcome of interest (ie, rehospitalization or death) or maximum 1 year of follow-up. The absolute risks of outcomes were assessed, and associated factors were evaluated. Based on age and comorbidities, patients were stratified in 4 groups: low (<75 years + 0 comorbidities), low intermediate (≥75 years/1 comorbidity), high intermediate (≥75 years + 1 comorbidity/2 comorbidities), and high risk of death (≥75 years + ≥2 comorbidities).

Results

In total, 4,202 patients (62.9% men) were identified. Within 1 year after surgery, 504 (12.0%) died and 2,456 (58.5%) were rehospitalized. Factors associated with death included older age (>75 years), chronic obstructive lung disease, heart failure, prior myocardial infarction, prior stroke, liver disease, and kidney disease. The 1-year risks of death among patients in low, low-intermediate, high-intermediate, and high risk of death were 3.6%, 10.3%, 19.6%, and 27.7%, respectively. Diabetes mellitus and chronic obstructive lung disease were associated with an increased incidence of rehospitalization, and the incidence of rehospitalization was similar among the 4 abovementioned groups (57.8%-62.8%).

Conclusions

Mortality and rehospitalization risks after mitral valve surgery varied substantially with age and comorbidities. High-risk patients with >25% 1-year mortality may be easily identified using readily available clinical features.

Trial Registration

In Denmark, registry-based studies that are conducted for the sole purpose of statistics and scientific research do not require ethical approval or informed consent by law. However, the study is approved by the data responsible institute (the Capital Region of Denmark [approval number: P-2019-348]) in accordance with the general data protection regulation.

Il testo completo di questo articolo è disponibile in PDF.

Graphical abstract




Image, graphical abstract

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : ICD, NCSP, PY, HR, CI


Mappa


© 2023  Elsevier Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 258

P. 140-148 - Aprile 2023 Ritorno al numero
Articolo precedente Articolo precedente
  • Public reporting of black participation in anti-hypertensive drug clinical trials
  • Michael D. Green, Mahalia R. Dalmage, Jay B. Lusk, Emilie F. Kadhim, Lesley A. Skalla, Emily C. O'Brien
| Articolo seguente Articolo seguente
  • Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry
  • Ankeet S. Bhatt, Lori B. Daniels, James de Lemos, Erica Goodrich, Erin A. Bohula, David A. Morrow, On behalf of the AHA COVID-19 CVD Registry Investigators

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.